Literature DB >> 17579298

Transforming growth factor beta 1 gene polymorphism in Japanese patients with systemic lupus erythematosus.

Biao Wang1, Akio Morinobu, Sugayo Kanagawa, Tomoko Nakamura, Seiji Kawano, Masahiro Koshiba, Hiroshi Hashimoto, Syunichi Kumagai.   

Abstract

To determine the role of transforming growth factor beta 1 (TGFbeta1) gene polymorphisms in the pathogenesis of systemic lupus erythematosus (SLE), we investigated the polymorphisms of T869C of the TGFbeta1 gene in 196 patients with SLE and 106 healthy controls by analyzing polymerase chain reaction-restriction fragment length polymorphism. The genotype and allele frequencies of T869C of the TGFbeta1 gene did not differ between SLE and healthy controls. However, compared to the TC and CC genotypes, the TT genotype was associated with anti-SS-A/Ro antibody production (p=0.029) and a higher incidence of aseptic necrosis (p=0.0097); the CC genotype had a higher frequency of anti-RNP antibody production compared to the patients with the TC and TT genotypes (p=0.023). These results suggest that T869C polymorphism of the TGFbeta1 gene is involved in the development of autoantibodies and the occurrence of aseptic necrosis in patients with SLE. Thus, TGFbeta1 polymorphism might be one of the genetic factors that explain the heterogeneity seen with SLE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579298

Source DB:  PubMed          Journal:  Kobe J Med Sci        ISSN: 0023-2513


  7 in total

1.  Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus.

Authors:  Arezou Rezaei; Vahid Ziaee; Fatemeh Tahghighi Sharabian; Sara Harsini; Maryam Mahmoudi; Samaneh Soltani; Maryam Sadr; Mohammad Hassan Moradinejad; Yahya Aghighi; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2015-01-30       Impact factor: 2.980

2.  The functional class evaluated in rheumatoid arthritis is associated with soluble TGF-β1 serum levels but not with G915C (Arg25Pro) TGF-β1 polymorphism.

Authors:  José Francisco Muñoz-Valle; Nora Magdalena Torres-Carrillo; Iris Paola Guzmán-Guzmán; Norma Torres-Carrillo; Sandra Luz Ruiz-Quezada; Claudia Azucena Palafox-Sánchez; Héctor Rangel-Villalobos; María Guadalupe Ramírez-Dueñas; Isela Parra-Rojas; Mary Fafutis-Morris; Blanca Estela Bastidas-Ramírez; Ana Laura Pereira-Suárez
Journal:  Rheumatol Int       Date:  2010-11-27       Impact factor: 2.631

3.  Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus.

Authors:  T L Rivera; P M Izmirly; B K Birnbaum; P Byrne; J B Brauth; M Katholi; M Y Kim; J Fischer; R M Clancy; J P Buyon
Journal:  Ann Rheum Dis       Date:  2008-07-14       Impact factor: 19.103

4.  Association of TGF-β1 +869C/T promoter polymorphism with susceptibility to autoimmune diseases: a meta-analysis.

Authors:  Li Zhang; Jun-wei Yan; Ying-Xin Wang; Ya-nan Wan; Jian-ping Li; Ping Liu; Bin Xu; Bing-xiang Wang; Wen-jia Peng; Fa-ming Pan; Jing Wang
Journal:  Mol Biol Rep       Date:  2013-05-05       Impact factor: 2.316

5.  The Potential effect of G915C polymorphism in regulating TGF-β1 transport into Endoplasmic Reticulum for cytokine production.

Authors:  Hani Susianti; Atma Gunawan; Jayarani Fatimah Putri; Basuki B Purnomo; Kusworini Handono; Handono Kalim
Journal:  Bioinformation       Date:  2014-08-30

6.  Changes to signal peptide and the level of transforming growth factor- β1 due to T869C polymorphism of TGF β1 associated with lupus renal fibrosis.

Authors:  Hani Susianti; Kusworini Handono; Basuki B Purnomo; Nashi Widodo; Atma Gunawan; Handono Kalim
Journal:  Springerplus       Date:  2014-09-10

7.  Genetic variation in the transforming growth factor-beta1 gene is associated with susceptibility to IgA nephropathy.

Authors:  Mai Tuyet Vuong; Sigrid Lundberg; Iva Gunnarsson; Lars Wramner; Maria Seddighzadeh; Mirjana Hahn-Zoric; Anders Fernström; Lars A Hanson; Lieu Thi Do; Stefan H Jacobson; Leonid Padyukov
Journal:  Nephrol Dial Transplant       Date:  2009-03-03       Impact factor: 5.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.